Palisade Capital Management »

Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by Palisade Capital Management

Quarter-by-quarter ownership of Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by Palisade Capital Management from 13F filings

Historical chart of Palisade Capital Management investment in Sarepta Therapeutics Inc Note 1.250 9/1

Tip: Access up to 7 years of quarterly data

All positions including Sarepta Therapeutics Inc Note 1.250 9/1 held by Palisade Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sarepta Therapeutics Inc Note 1.250 9/1 by Palisade Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.1M 2.1M 1.01
2023-09-30 $2.3M 2.1M 1.12

More positions owned by Palisade Capital Management

Applied Industrial Technologies (AIT)
Raymond James Financial (RJF)
Apple (AAPL)
Littelfuse (LFUS)
Rb Global (RBA)
Blackbaud (BLKB)
Ida (IDA)
Acadia Healthcare (ACHC)
Avient Corp (AVNT)
Mueller Industries (MLI)
EastGroup Properties (EGP)
Performance Food (PFGC)
Rli (RLI)
Saia (SAIA)
Repligen Corporation (RGEN)

View all positions for Palisade Capital Management

Top funds holding Sarepta Therapeutics Inc Note 1.250 9/1

Wolverine Asset Management
Calamos Advisors
Braidwell
Highbridge Capital Management
Davidson Kempner Capital Management
Readystate Asset Management
Bank of America Corporation
Lazard Asset Management
Tenor Capital Management
D. E. Shaw & Co
Bank Of Montreal
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
Steelhead Partners
Capstone Investment Advisors
Weiss Asset Management LP[1

View all funds holding Sarepta Therapeutics Inc Note 1.250 9/1